Food and Drug Administration (FDA) announced on January 28th, 2025, that Ozempic (semaglutide, Novo Nordisk) is now approved to reduce the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD)
Ernhrung im Sport
Immune and Host Defence Sets: Antimicrobial peptide research in vitro
The types of adverse events seen in TRIUMPH-1 were generally consistent with trials of other incretin-based therapies
Each one needs protectionfrom free radicals, oxidative stress, and the challenges of daily life
In a large scale randomized controlled study, women taking prenatal vitamins at least 1 month before conception were noted to have higher number of confirmed pregnancies and shorter time to conception compared to women only taking trace elements like vitamin C and Zinc